Mazdutide.
Mazdutide (IBI362) is a long‑acting dual GLP‑1/glucagon receptor agonist developed for chronic weight management and type 2 diabetes.[1][2] Phase 2 and 3 clinical trials have demonstrated substanti...
Cited protocol example—review and confirm.
Reference syringe capacity
Calculated volume exceeds selected capacity
Calculated volume: 150 units. The selected 1 mL reference capacity is 100 units.
Calculated volume reference
150.0 units
1mL syringe
Calculated volume exceeds selected capacity
Calculated volume: 150.0 units. Select another reference capacity or review the calculation inputs.
Cited protocol & reconstitution guide
Source-backed reference fields by phase, including any volume fields authored in the cited guide.
Weeks 1–4
2.5 mg (2,500 mcg)
Weeks 5–8+
5 mg (5,000 mcg)
| Phase | Reference amount | Units / volume |
|---|---|---|
| Weeks 1–4 | 2.5 mg (2,500 mcg) | 150 units (1.50 mL) |
| Weeks 5–8+ | 5 mg (5,000 mcg) | 300 units (3.00 mL) |
Reconstitution by vial size
Calculated volume for each cited phase and vial variant. The highlighted column matches the selection above.
| Phase | 5 mg 3 mL water | 10 mg 3 mL water |
|---|---|---|
| Weeks 1–4 | 150 u 1.50 mL | 75 u 0.75 mL |
| Weeks 5–8+ | 300 u 3.00 mL | 150 u 1.50 mL |
Cited guide source: View source